|
Market Closed -
Nasdaq Stockholm
09:30:00 07/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2.100 SEK | +3.96% |
|
+16.02% | +10.53% |
| 02/09 | Enzymatica CEO buys additional shares | FW |
| 01/09 | Enzymatica CEO buys 33 384 shares | FW |
| Market Cap | 51Cr 44Cr 41Cr 38Cr 70Cr 4.82TCr 71Cr 488.87Cr 188.97Cr 2.47TCr 191.43Cr 187.24Cr 7.86TCr | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 48Cr 41Cr 39Cr 35Cr 66Cr 4.52TCr 66Cr 458.07Cr 177.06Cr 2.31TCr 179.37Cr 175.45Cr 7.37TCr | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ENZY | Delayed | |
Deutsche Boerse AG
| EN9 | Delayed | |
|
Börse Stuttgart
| EN9 | Delayed | |
|
Boerse Muenchen
| EN9 | Real-time |
| 1 day | +3.96% | ||
| 1 week | +16.02% | ||
| Current month | +13.82% | ||
| 1 month | +13.82% | ||
| 3 months | -25.27% | ||
| 6 months | +2.94% | ||
| Current year | +10.53% |
| 1 week | 1.8 |  | 2.22 |
| 1 month | 1.65 | | 2.22 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 12 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Chief Tech/Sci/R&D Officer | - | 27/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/07/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 01/04/26 | Sell | Responsable ventes & marketing | 40,000 | 0.0165% | ||
| 30/12/25 | Buy | Chairman | 20,000 | 0.0082% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.96% | +16.02% | -11.76% | -37.87% | 5.13Cr | |
| -0.88% | -2.15% | +58.05% | +105.26% | 1,02400Cr | |
| -1.15% | +2.68% | +54.25% | +74.19% | 66TCr | |
| -1.44% | +0.38% | +20.65% | +76.13% | 45TCr | |
| -0.95% | -1.42% | +28.96% | +40.10% | 35TCr | |
| -3.18% | +1.39% | +20.66% | +43.86% | 30TCr | |
| +0.30% | +0.60% | -0.40% | +13.54% | 25TCr | |
| -1.55% | +1.11% | +54.15% | +75.59% | 24TCr | |
| +0.02% | +1.17% | -14.59% | -54.96% | 21TCr | |
| -0.15% | +3.65% | +31.24% | +103.39% | 19TCr | |
| Average | -0.48% | +2.30% | +24.12% | +43.92% | 36.78TCr | |
| Weighted average by Cap. | -1.04% | +0.62% | +37.20% | +67.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.56Cr 3.92Cr 3.69Cr 3.37Cr 6.29Cr 431.02Cr 6.31Cr 44Cr 17Cr 220.73Cr 17Cr 17Cr 703.08Cr | 5.39Cr 4.64Cr 4.36Cr 3.98Cr 7.44Cr 509.78Cr 7.47Cr 52Cr 20Cr 261.06Cr 20Cr 20Cr 831.55Cr |
| Net income | -5.32Cr -4.57Cr -4.3Cr -3.93Cr -7.34Cr -502.93Cr -7.37Cr -51Cr -20Cr -257.55Cr -20Cr -20Cr -820.38Cr | -5.19Cr -4.46Cr -4.2Cr -3.83Cr -7.17Cr -490.74Cr -7.19Cr -50Cr -19Cr -251.31Cr -19Cr -19Cr -800.5Cr |
| Net Debt | -7.3Cr -6.28Cr -5.91Cr -5.39Cr -10Cr -690.49Cr -10Cr -70Cr -27Cr -353.6Cr -27Cr -27Cr -1.13TCr | -3.21Cr -2.76Cr -2.6Cr -2.37Cr -4.43Cr -303.69Cr -4.45Cr -31Cr -12Cr -155.52Cr -12Cr -12Cr -495.37Cr |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | SEK 2.100 | +3.96% | 1,49,511 |
| 04/26/04 | SEK 2.020 | 0.00% | 1,18,324 |
| 03/26/03 | SEK 2.020 | +9.19% | 2,37,957 |
| 02/26/02 | SEK 1.850 | +0.82% | 1,16,529 |
| 01/26/01 | SEK 1.835 | -0.54% | 43,567 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
